Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital

Hypertensive disorders in women with peripartum cardiomyopathy: insights from the ESC EORP PPCM Registry

Research output: Contribution to journalJournal articleResearchpeer-review


  1. Three decades of heart transplantation: experience and long-term outcome

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Advanced heart failure: guideline-directed medical therapy, diuretics, inotropes, and palliative care

    Research output: Contribution to journalReviewResearchpeer-review

  3. Healthcare resource use of patients with transthyretin amyloid cardiomyopathy

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Suspicion, screening, and diagnosis of wild-type transthyretin amyloid cardiomyopathy: a systematic literature review

    Research output: Contribution to journalReviewResearchpeer-review

  • Alice M Jackson
  • Mark C Petrie
  • Alexandra Frogoudaki
  • Cécile Laroche
  • Finn Gustafsson
  • Bassem Ibrahim
  • Alexandre Mebazaa
  • Mark R Johnson
  • Petar M Seferovic
  • Vera Regitz-Zagrosek
  • Amam Mbakwem
  • Michael Böhm
  • Hawani S Prameswari
  • Doaa A Fouad
  • Sorel Goland
  • Albertino Damasceno
  • Kamilu Karaye
  • Hasan A Farhan
  • Righab Hamdan
  • Aldo P Maggioni
  • Karen Sliwa
  • Johann Bauersachs
  • Peter van der Meer
  • PPCM Investigators Group
View graph of relations

AIMS: Hypertensive disorders occur in women with peripartum cardiomyopathy (PPCM). How often hypertensive disorders co-exist, and to what extent they impact outcomes, is less clear. We describe differences in phenotype and outcomes in women with PPCM with and without hypertensive disorders during pregnancy.

METHODS AND RESULTS: The European Society of Cardiology EURObservational Research Programme PPCM Registry enrolled women with PPCM from 2012-2018. Three groups were examined: (i) women without hypertension (PPCM-noHTN); (ii) women with hypertension but without pre-eclampsia (PPCM-HTN); (iii) women with pre-eclampsia (PPCM-PE). Maternal (6-month) and neonatal outcomes were compared. Of 735 women included, 452 (61.5%) had PPCM-noHTN, 99 (13.5%) had PPCM-HTN and 184 (25.0%) had PPCM-PE. Compared to women with PPCM-noHTN, women with PPCM-PE had more severe symptoms (New York Heart Association class IV in 44.4% vs. 29.9%, P < 0.001), more frequent signs of heart failure (pulmonary rales in 70.7% vs. 55.4%, P = 0.002), a higher baseline left ventricular ejection fraction (LVEF) (32.7% vs. 30.7%, P = 0.005) and a smaller left ventricular end-diastolic diameter (57.4 ± 6.7 mm vs. 59.8 ± 8.1 mm, P = 0.001). There were no differences in the frequencies of death from any cause, rehospitalization for any cause, stroke, or thromboembolic events. Compared to women with PPCM-noHTN, women with PPCM-PE had a greater likelihood of left ventricular recovery (LVEF ≥ 50%) (adjusted odds ratio 2.08, 95% confidence interval 1.21-3.57) and an adverse neonatal outcome (composite of termination, miscarriage, low birth weight or neonatal death) (adjusted odds ratio 2.84, 95% confidence interval 1.66-4.87).

CONCLUSION: Differences exist in phenotype, recovery of cardiac function and neonatal outcomes according to hypertensive status in women with PPCM.

Original languageEnglish
JournalEuropean Journal of Heart Failure
Issue number12
Pages (from-to)2058-2069
Number of pages12
Publication statusPublished - Dec 2021

Bibliographical note

© 2021 The Authors. European Journal of Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.

    Research areas

  • Heart failure, Hypertension, Peripartum cardiomyopathy, Pre-eclampsia, Pregnancy

ID: 68255169